Rock Springs Capital Management LP 13D and 13G filings for PhaseBio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 3:01 pm Sale | 2022-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Rock Springs Capital Management LP | 0 0.000% | -2,581,299 (Position Closed) | Filing |
| 2022-02-14 6:24 pm Purchase | 2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Rock Springs Capital Management LP | 2,581,299 5.370% | 1,266,925 (+96.39%) | Filing |
| 2021-02-16 4:32 pm Sale | 2020-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Rock Springs Capital Management LP | 1,314,374 4.480% | -337,500 (-20.43%) | Filing |
| 2020-11-16 4:59 pm Purchase | 2020-11-06 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Rock Springs Capital Management LP | 1,651,874 5.630% | 526,874 (+46.83%) | Filing |